[ET Net News Agency, 2 December 2025] Daiwa raised the target price for BeOne Medicines
(06160) to HKD240 from HKD210 and maintained the "buy" rating.
The research house said it revises up 2025-27E top line by 2-4% on higher Brukinsa
revenue. (rc)